Skip to main content

Table 1 Baseline characteristics by AKI stage

From: Association of markers of endothelial dysregulation Ang1 and Ang2 with acute kidney injury in critically ill patients

Variable

No AKI

AKI stage 1

AKI stage 2

AKI stage 3

N

442

376

17

113

Age, years

55.0 (16.8)

56.8 (16.0)

47.6 (18.0)

53.0 (15.0)

BMI, kg/m2

28.1 (18)

32.0 (18.3)

30 (6.3)

32.4 (11.8)

Creatinine, mg/dL

0.86 (0.39)

1.14 (0.53)

0.74 (0.22)

3.74 (3.08)

SOFA score

3 (2.5)

4.7 (2.8)

3.8 (2.7)

7.5 (3.2)

APACHE III

42.2 (24.3)

55.1 (27)

53.6 (16.5)

66.5 (34.8)

Caucasian

442 (100)

376 (100)

17 (100)

113 (100)

Female gender

176 (39.8)

119 (31.7)

8 (47.1)

41 (36.3)

Source of ICU admission

 Medical

228 (51.6)

200 (53.2)

8 (47.1)

83 (73.5)

 Surgical

214 (48.4)

176 (46.8)

9 (52.9)

30 (26.6)

Death within 28 days

14 (3.2)

63 (16.8)

3 (17.7)

31 (27.4)

Comorbidities

 Chronic kidney disease

12 (2.7)

34 (9.0)

0 (0)

20 (17.7)

 Diabetes mellitus

86 (19.5)

111 (29.5)

7 (41.2)

30 (26.6)

 Cirrhosis

36 (8.1)

35 (9.3)

3 (17.7)

10 (8.9)

 Current smoking

264 (59.7)

205 (54.5)

9 (52.9)

62 (54.9)

Source of critical illness

 Pneumonia

85 (19.2)

87 (23.1)

5 (29.4)

17 (15.0)

 Sepsis

269 (60.9)

269 (71.5)

14 (82.4)

80 (70.8)

 Other

74 (16.7)

79 (21.0)

3 (17.7)

21 (18.6)

  1. AKI acute lung injury, APACHE Acute Physiology, Age, Chronic Evaluation, BMI body mass index, ICU intensive care unit, SOFA Sequential Organ Failure Assessment